Trial intelligence / Profile preview

Ciprofol versus dexmedetomidine for long-term sedation in mechanically ventilated ICU patients

ChiCTR2300078671Phase 4Recruiting

Sponsor
Changzhou First People's Hospital
Start
Mar 2023
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in None comparing Dexmedetomidine group with Ciprofol group (2 arms). Primary endpoints: Proportion of time in target sedation range and Bradycardia and hypotension incidence and duration. Started Mar 2023; status: recruiting.

02

Drugs

ciprofoldexmedetomidine

Beyond the preview

Go deeper on ChiCTR2300078671.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300078671.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call